Search bioRxiv⌕ Search

Biology subjects

He, L.

Publications and source records attributed to He, L..

At least 19 recordsLinked to original sources

Integrative multi-omics decoding of the host response to Klebsiella pneumoniae infection reveals an itaconate-centred metabolic-immune axis and a spatially organised inflammatory programme

Background: Klebsiella pneumoniae (Kp) is a leading cause of hospital and community acquired pneumonia and bacteraemia, and hypervirulent and carbapenem resistant lineages continue to expand worldwide. Although individual omics layers of Kp infection have been profiled, the host-level molecular logic that connects transcriptional, cellular, metabolic and spatial programmes has not been systematically integrated. Methods: We curated 16 public datasets spanning four modalities-bulk and dual host pathogen RNA-seq (six datasets; 118 libraries), single-cell RNA-seq (four datasets; {approx}164,000 cells), untargeted/targeted metabolomics (four datasets; 1,842 molecular features) and Visium spatial transcriptomics (two datasets; {approx}11,400 spots) covering murine lung infection models, hypervirulent and classical Kp strains, carbapenem-resistant isolates and human clinical specimens. Datasets were harmonised through a standardised pipeline (Salmon/DESeq2; Scanpy/Harmony; MetaboAnalyst; RCTD/spacexr), and integrated by WGCNA, GSVA, CellChat, Monocle3, SCENIC, joint-pathway analysis, RCTD deconvolution, and machine-learning feature selection (LASSO, random forest, SVM-RFE, XGBoost) with 1,000x bootstrap internal validation and independent external validation. Results: Kp infection evoked a coherent 920 gene neutrophil inflammatory response ({approx}520 up-/{approx}400 down-regulated genes) dominated by IL-17/TNF/NF-{kappa}B signalling, neutrophil degranulation, HIF-1-linked glycolysis and itaconate biosynthesis. A turquoise co-expression module (r = 0.86 with infection status) yielded a ten-gene hub signature (IRG1, S100A9, IL1B, CXCL2, SLC7A11, HMOX1, PTGS2, NFKBIA, LST1, FCGR3B). Single-cell profiling resolved twelve major lung lineages and eleven myeloid substates, tracing a Monocle3 trajectory from Cxcr2hi inflammatory neutrophils through an Irg1/Slc7a11hi oxidative phase into Cxcr4hi/Trem2hi suppressive states; CellChat identified S100A8/A9-TLR4 and CXCL2-CXCR2 as the most amplified axes (8.5x and 4.2x). Metabolomics revealed 30-fold pulmonary itaconate accumulation together with succinate and lactate elevation, glucose/glutamine depletion and glutathione collapse, and joint-pathway analysis positioned the TCA-cycle itaconate and ferroptosis modules as the strongest convergent perturbations. Spatial transcriptomics mapped these programmes onto five anatomical niches, with IRG1 expression peaking in the infection core (58% neutrophil content) and declining radially. A ten-gene host-response classification model reached AUC=0.958 in discovery, 0.937 in internal validation and 0.884-0.912 in two independent external cohorts (Brier score 0.071). Conclusions: By vertically integrating public multi-omics data, we define an itaconate-centred metabolic-immune axis that couples inflammatory myeloid expansion to spatially segregated metabolic niches, and we deliver a validated host-side molecular signature that discriminates Kp infection from non-infected states.

microbiology↗

An OmpX mRNA-LNP vaccine induces protective humoral and cellular immunity against Klebsiella pneumoniae in a C57BL/6 mouse model

Klebsiella pneumoniae (KP) poses a significant threat to global public health, and effective preventive measures are urgently needed. The widespread antibiotic resistance of KP underscores the critical need for vaccine-based strategies. Although numerous vaccine candidates against KP have been investigated, none has yet been licensed. mRNA-LNP vaccines against KP have only recently begun to be explored, and their ability to deliver conserved outer membrane protein antigens remains largely untested. In this study, we constructed an mRNA vaccine encoding the highly conserved outer membrane protein X (OmpX) of KP-the first mRNA-LNP vaccine targeting this antigen-and evaluated its immunogenicity and protective efficacy in mice. Immunoinformatics analyses predicted concordance between the in silico and in vivo outcomes: bioinformatics tools were used to evaluate the antigenicity, immunogenicity, physicochemical parameters, and secondary and tertiary structures of OmpX, and the C-ImmSim server was used to simulate the vaccine-elicited immune responses. We then performed mouse immunization and challenge experiments to characterize the humoral and cellular immune responses induced by the OmpX vaccine. The mRNA vaccine was immunogenic in mice, eliciting high titers of OmpX-specific antibodies. OmpX-Fc mRNA-LNPs also induced robust cell-mediated immunity, with significantly elevated IFN-{gamma} and IL-4 levels indicative of combined Th1/Th2 cellular responses. Serum from OmpX-immunized mice promoted significantly greater complement-mediated KP cell lysis than serum from the alum or luciferase mRNA-LNP control groups. Notably, OmpX-Fc mRNA-LNP immunization conferred complete protection against lethal KP challenge, with 100% survival and a significant reduction in visceral bacterial burden. These data establish a promising mRNA vaccine strategy for inducing broad immune responses and promoting serotype-independent immunity against KP.

microbiology↗

Integrative reanalysis of public intracellular and vaccine-challenge transcriptomes, informed by single-cell and metabolomic atlases, refines antigen prioritisation for next-generation veterinary Brucella vaccines

Brucellosis is the most widespread bacterial zoonosis and a leading cause of abortion and infertility in cattle, sheep, goats and pigs. The live vaccines licensed for livestock (B. abortus S19 and RB51, B. melitensis Rev.1) give incomplete protection, retain residual virulence and induce antibodies that are indistinguishable from those of field infection, and no human vaccine is licensed. Antigen discovery for safer subunit and mRNA alternatives has proceeded one candidate at a time, so it remains unclear which immunogenic proteins are abundant in the intracellular niche that protective immunity must recognise. We reanalysed four public data layers: dual RNA-sequencing of intracellular B. abortus and infected murine macrophages (GSE100914), splenic transcriptomes from vaccinated and challenged mice (GSE254248), and single-cell (PRJCA054635) and metabolomic (ST003696, ST003692) atlases. Intracellular residence induced 704 genes and repressed 249, enriching translation functions 2.9-fold. Omp28/BP26 was the second most abundant intracellular transcript (35,652 TPM; log2FC 4.25), whereas the lipoproteins omp16, omp10 and omp19 were 116-637-fold less abundant. Vaccination left a germinal-centre and TCF1+ memory imprint rather than an effector-cytokine signature. A composite score combining abundance, induction and surface exposure reorders the candidate panel, placing Omp28/BP26 and omp2b above current candidates and defining concrete priorities for veterinary vaccine development.

immunology↗

Rationally Engineered Self-Assembling Protein Nanoparticles for Allergen-Specific Peanut Allergy Immunotherapy

Peanut allergy is a prevalent immunoglobulin E (IgE)-mediated food allergy that can cause life-threatening anaphylaxis. Current treatment options provide limited efficacy and variable durability of protection. While allergen-displaying virus-like particles (VLPs) have shown promise, their development is often constrained by limited design flexibility and manufacturing complexity. Here, we develop self-assembling protein nanoparticles (SApNPs) displaying the major allergens Ara h 2 and Ara h 6 as a modular platform for peanut allergy immunotherapy. Using the 60-mer TIP60 scaffold, we engineer nanoparticles by expanding particle size through -helical insertion and replacing the human myosin-X segment with evolutionarily distant catfish homologs, followed by structure-guided and evolution-inspired optimization to enhance thermostability while minimizing human sequence content. Formulated with a Toll-like receptor 9 (TLR9) agonist, these allergen-displaying SApNPs confer robust protection against peanut-induced anaphylaxis in both prophylactic and therapeutic settings. Mechanistically, SApNPs exhibit prolonged lymph node retention, sustained presentation on follicular dendritic cells, and enhanced germinal center responses compared with soluble allergens, promoting allergen-specific IgG and functional T cell responses while limiting IgE escalation. Collectively, these findings establish allergen-displaying SApNPs as a rationally engineered, scalable, and modular platform for peanut allergy treatment with potential applicability to other allergic diseases.

immunology↗

Xenoglycosylation of the HIV-1 Glycan Shield Promotes Cross-Clade Neutralization and Diverse Human Antibody Lineages

Despite advances in HIV-1 envelope glycoprotein (Env)-based vaccine design, eliciting broadly neutralizing antibodies (bNAbs) remains a central challenge. Here, we identify core (1,3)-fucose as a key modulator of neutralizing antibody (NAb) induction and breadth. Uncleaved prefusion-optimized (UFO) trimers and self-assembling protein nanoparticles (SApNPs) produced in High Five (Hi5) insect cells incorporate core (1,3)-fucose into the Env glycan shield. Crystal structures of Hi5-produced BG505 UFO trimers in complex with bNAbs confirm native-like Env architecture and epitope presentation. In wild-type mice, these trimers and SApNPs elicit robust autologous and heterologous NAb responses. We then engineer Chinese hamster ovary (CHO) cells to co-express three insect- and plant-derived core (1,3)-fucosyltransferases. The resulting immunogens carry fucosylated mammalian glycans and elicit cross-clade NAb responses in mice, supporting an important role for core (1,3)-fucose in broadened neutralization. Env-specific IgE responses suggest engagement of associated immune pathways during vaccination. In ATX-Gx humanized mice, core (1,3)-fucosylated, glycan-trimmed Env elicits detectable cross-clade neutralization by week 11. Single-cell analysis identifies distinct human antibody lineages with cross-clade activity and noncanonical Env recognition. Repertoire and functional analyses uncover putatively related lineage members across two animals within the same group. Together, these findings support xenoglycosylation as a promising, germline-agnostic strategy for HIV-1 vaccine design.

immunology↗

Niche-dependent epistasis within the cancer genome shapes metastatic fitness

Epistasis, the genetic interaction between loci, directs non-additive genotype-to-phenotype outcomes. Within a multicellular organism, how the tissue niche (E) shapes gene-by-gene epistasis (GxG) and its phenotypic consequences remains poorly studied. Using tumor lung metastasis as an experimental model, we mapped GxGxE through combinatorial CRISPR perturbation coupled with depletion of defined host myeloid populations in mice. The metastatic niche first selects disseminated tumor cells on GxG epistatic fitness, then drives transcriptome convergence regardless of genotype. Removing anatomically distinct myeloid populations reshaped the metastatic epistasis landscape despite identical tumor genotypes. Gene-by-gene-by-environment epistasis therefore operates at the organismal level, with interaction magnitude and sign set by niche cells. Beyond metastasis, our data suggest that the tissue niche conditions how genetic interactions translate into divergent phenotypes.

genetics↗

Autophagosome-tethering compounds selectively lower mutant ataxin-3 in preclinical models of spinocerebellar ataxia type 3

Spinocerebellar ataxia type 3 (SCA3) is most common subtype of autosomal dominant spinocerebellar ataxia worldwide and the most prevalent CAG expansion disorder in the east Asian population, but disease-modifying therapies remain unavailable. SCA3 is caused by the accumulation of polyglutamine- (polyQ-) expanded mutant ataxin-3 (mAtxn3), while the wild-type ataxin-3 (wtAtxn3) plays an important cellular role. Thus, allele-selective clearance of mAtxn3 without affecting wtAtxn3 is highly desired for SCA3 treatment. To achieve this goal, we tested previously reported compounds that have been shown to selectively degrade the Huntingtons disease causing mutant HTT protein by tethering the expanded polyQ to the autophagosome protein LC3. Here, we demonstrated that two of these compounds, AN2 and GW5074, selectively reduced both soluble and aggregated mAtxn3 with expanded polyQ (84Q), but not wtAtxn3, in both cellular and mouse models of SCA3. Mechanistically, both compounds lowered mAtxn3 by enhancing its autophagic degradation without obvious activation of global autophagy. At the molecular level, both compounds increased mAtxn3-LC3 interaction and colocalization to enhance the allele-selectively autophagic degradation of mAtxn3. Phenotypically, both compounds rescued cell viability and ATP content of SCA3 cellular models. In SCA3 patient pluripotent stem cells (iPSCs) derived cortical neurons, both compounds allele-selectively reduced mAtxn3 and partially rescued neurite shortening. Importantly, in a well-established SCA3 transgenic mouse model (MJD84.2), intracerebroventricular, intraperitoneal, and oral administration allele-selectively reduced mAtxn3 in multiple brain regions and rescued motor function deficits. Oral dosing achieved nanomolar cerebellar exposure and showed no overt liver, kidney, or glial toxicity over 28 days. Analyses of 1303 Chinese patients with SCA3 and ATXN3 constructs of different polyglutamine lengths further supported the compounds polyQ length-dependent activity with relative sparing of normal-length ataxin-3. Together, these findings provide preclinical proof of concept that utilizing orally available small molecule compounds to allele-selectively enhance mAtxn3 autophagic degradation for SCA3 treatment. One-sentence summarySmall-molecule autophagosome-tethering compounds selectively lower mutant ataxin-3 through an LC3- and autophagy-dependent mechanism and improve disease-related phenotypes in preclinical models of SCA3.

neuroscience↗

Patronin condensation integrates recognition, protection and organization of microtubule minus ends

Microtubule minus ends are central to non-centrosomal microtubule organization, yet how their recognition, protection and molecular organization are integrated remains unclear. Here we show that Drosophila Patronin forms dynamic condensates at microtubule minus ends through a prion-like domain (PrLD). PrLD-mediated condensation cooperates with the CKK domain and a second CKK-independent recognition region to convert weak or broadly distributed microtubule-binding activities into persistent minus-end recognition and tracking. Replacing the PrLD with a heterologous phase-separating HNRNPA1 IDR restores minus-end targeting, indicating that condensation capacity rather than PrLD primary sequence is critical. Patronin condensates further form a protective cap that resists minus-end depolymerization and recruit the cytoskeletal regulators Sas-4, Katanin and Ena. Disrupting PrLD multivalency impairs Patronin localization at multiple developmental sites and causes early organismal lethality. Thus, Patronin condensation creates a physiologically essential microtubule minus-end compartment coupling end recognition, stabilization and cytoskeletal organization.

cell biology↗

Cytokine-induced nuclear translocation of STAT1 via a non-transferable NLS

The targeting function of nuclear localization signals (NLSs) is generally considered independent of a protein's native sequence or fold and is readily transferable to heterologous cargos. Contrary to this paradigm, rapid nuclear translocation of phosphorylated STAT1 (pSTAT1) following cytokine stimulation requires importin {beta}, Ran-GTP, and the importin 5 isoform, which recognizes a non-transferable NLS. Here, we present cryo-EM structures of pSTAT1 bound to importin 5, revealing an asymmetric 2:1 complex that diverges from canonical NLS-mediated cargo recognition. Importin 5 occupies the DNA-binding groove of the pSTAT1 dimer, with a single STAT1 N-terminal domain positioning the C-terminal Armadillo repeats 9-10 (S1B domain) orthogonal to the DNA-binding interface. This interface is also targeted by the Ebola virus protein VP24, an antagonist of interferon signaling. We further show that Ran-GTP alone is insufficient to trigger nuclear release of pSTAT1, which additionally requires the exportin CAS. A cryo-EM reconstruction of the CAS-Ran-GTP-5 complex, supported by in vitro competition assays, demonstrates that CAS and pSTAT1 are mutually exclusive ligands for importin 5. Together, these findings define the molecular choreography of cytokine-induced STAT1 nuclear translocation and release, establishing a general paradigm for STAT family signaling.

biochemistry↗

Ultra-fast and scalable high-resolution full-length single-cell RNA sequencing using CHART-seq

Plate-based full-length single-cell RNA sequencing resolves transcript structure details but remains difficult to scale because each cell usually requires a separate library. Here we developed CHART-seq (Combinatorial Heteroduplex Assay via Recombinant Tn5), which uses orthogonally indexed Tn5 complexes to tagment RNA/cDNA heteroduplexes and permits early sample pooling. The workflow processed up to 96 cells per library, was compatible with 384-well expansion, and completed library preparation within 3 h at a reagent cost below US$1 per cell. At matched sequencing depth, CHART-seq detected more genes and annotated isoforms than Smart-seq2, Smart-seq3, Flash-seq and SHERRY2, while retaining broad genebody coverage and reproducible expression estimates. In the CHART-seq results of vascular smooth muscle cells, TGF-{beta}1 pretreatment before PDGF-BB exposure partly restored contractile features, suppressed a PDGF-associated inflammatory programme, and induced a distinct metabolic-matrix response with coordinated transcript-usage changes. These biological findings remain exploratory because independent biological replicates were unavailable. CHART-seq provides a rapid, scalable route to full-length single-cell transcript profiling with gene-programme and candidate isoform resolution.

genomics↗

Chronic lower limb pain is not associated with a loss of inhibitory neurons in the human lumbar spinal dorsal horn

The spinal dorsal horn is the primary processing site of nociceptive sensory input from the periphery. Excitatory spinal interneurons releasing glutamate can amplify this information before it is sent to the brain, whereas inhibitory neurons releasing GABA and/or glycine can suppress the outflow of nociceptive signals. An imbalance favoring excitation is thought to underlie certain aspects of chronic pain. Although rodent studies have identified spinal mechanisms underlying hyperalgesia and allodynia, little is known about the anatomical changes associated with chronic pain in the human spinal cord, a gap in knowledge we sought to address in this study. Using immunohistochemistry and in situ hybridization on lumbar spinal cord tissue recovered from organ donors, we characterized neuronal size and density across the human dorsal horn and confirmed the presence of the human equivalent of the lateral spinal nucleus in many individuals. Chronic lower limb pain was not associated with changes in neuronal density in the dorsal horn. Likewise, the ratio of excitatory (SLC17A6+) to inhibitory (PAX2+) neurons remained consistent across laminae for age, sex and chronic pain state, providing no evidence for selective loss of inhibitory neurons with chronic pain in humans. We found no differences in the size or density of the postsynaptic markers Homer1 and gephyrin between groups, suggesting glutamatergic and GABAergic postsynaptic sites remain structurally stable. These findings provide a thorough evaluation of cellular anatomy of the human dorsal horn and form a foundation for future studies investigating neuronal changes that may contribute to chronic pain in humans.

neuroscience↗

Analysis of Rare Coding Variation Identifies New Genetic Contributors to Schizophrenia

In this study, we present the largest rare coding variant association study of schizophrenia to date, with 87,959 schizophrenia cases and 150,587 controls. We identify 16 genes at exome-wide significance: SETD1A, ZMYM2, HERC1, RB1CC1, SCAF1, XPO7, SP4, FYN, PPP3CA, CUL1, HDAC9, JARID2, ATP9A, PTK2, STAG1, and SCN2A, and an additional 24 at a 5% false discovery rate. Cases carrying ultra-rare, damaging variants, primarily protein-truncating and deleterious missense mutations, show strong enrichment in constrained genes with consistent effects across ancestries. Half of the 40 identified genes overlap with those implicated in developmental delay, autism, or bipolar disorder, underscoring shared neurodevelopmental risk. All 40 genes identified are highly expressed in excitatory and inhibitory neurons, and their expression patterns span diverse developmental stages. Functionally, the identified genes implicate chromatin regulation, protein degradation, and synaptic function. Overall, our results advance understanding of the genetic architecture of schizophrenia, provide a foundation for modeling risk genes in cellular and animal systems, and offer a framework for future work toward biologically informed patient stratification.

genetics↗

Spatially resolved multimodal hallmarks of response to neoadjuvant immunotherapies in the melanoma ecosystem in 2D and 3D

Neoadjuvant immunotherapy has transformed cancer treatment, yet the spatial molecular architecture governing response and resistance across distinct immune checkpoint blockade (ICB) regimens remains poorly defined. We assembled the largest neoadjuvant ICB (NICB) spatial multi-omics cohort to date, profiling over 112 million cells at single-cell resolution across three melanoma ICB regimens using MERFISH spatial transcriptomics, multiplexed immunofluorescence, and scRNA-sequencing. These analyses revealed the full multicellular spatial architecture of the NICB tumor microenvironment, including mature TLS with germinal centers, TCF7+ stem-like T cells, myeloid cells organized into spatially distinct cellular neighborhoods with unique intercellular signaling circuits, and CCL19/CCL21-expressing fibroblasts as a previously unrecognized stromal scaffold sustaining these immune hubs. We developed three purpose-built computational tools that together enabled comprehensive quantification of this microenvironment for the first time: SCIRA for whole-slide single-cell receptor-ligand quantification, GCSCAN for molecularly grounded TLS and germinal center structural delineation, and PathNet-TLS for automated TLS detection on H&E images. Applying these tools across the cohort, we defined the immune and stromal composition and cellular neighborhood organization distinguishing responders from non-responders. We also quantified cell-cell interactions and regimen-specific immune architectures, including a markedly stronger mature TLS/germinal center response with IPI-NIVO than NIVO-RELA. Importantly, GCSCAN-quantified TLS and germinal center density each stratified disease-free survival, with responders that lack germinal centers having an elevated risk of relapse. Open-top light-sheet imaging and CODA-based 3D reconstruction further uncovered interconnected germinal center-TLS tunnels invisible to standard 2D histopathology. These findings establish a discovery-to-tool paradigm linking single-cell tumor microenvironment interrogation to clinically deployable computational pathology for biomarker-driven NICB assessment across cancer types.

cancer biology↗

Exosome-Mediated Bidirectional Signaling Regulates Glioma Stem-Cell Homeostasis and Radiation-Induced Plasticity

Background: Glioblastoma (GBM) is an aggressive brain malignancy characterized by therapeutic resistance and frequent recurrence. Glioma-initiating cells (GICs), also known as glioma stem cells (GSCs), contribute to these features through self-renewal and resistance to genotoxic stress. Radiation therapy can paradoxically replenish the GIC compartment by inducing stem-like properties in non-stem glioma cells. We investigated whether exosomes mediate bidirectional communication that maintains the balance between GIC and non-stem populations at steady state and following irradiation. Methods: Exosomes were isolated from GIC-enriched gliomaspheres and differentiated monolayer cultures of the patient-derived GBM lines HK-374 and HK-390. Vesicles were characterized by transmission electron microscopy, nanoparticle analysis, and detection of CD63. Recipient cells were exposed to exosomes with or without 4 Gy irradiation. GIC abundance and function were evaluated using a ZsGreen-ornithine decarboxylase degron reporter, sphere-formation assays, and extreme limiting dilution analysis. Exosomal protein cargo was characterized by liquid chromatography-tandem mass spectrometry and Gene Ontology enrichment analysis. Single-cell RNA sequencing was used to evaluate changes in cellular composition upon exosome treatment. Results: Isolated vesicles displayed characteristic exosomal morphology, a mean diameter of 41.6 +/- 14.7 nm, and CD63 expression. Irradiation produced a 12-fold increase in GIC reporter-positive cells among initially reporter-negative differentiated cells. Gliomasphere-derived exosomes significantly and dose-dependently suppressed this radiation-induced phenotype conversion and reduced functional GIC frequency and self-renewal in both patient-derived lines. Conversely, exosomes from GIC-depleted monolayer cultures increased reporter-positive cells two- to three- fold and enhanced the frequency and self-renewal of existing GICs. Proteomic analysis identified 1,796 exosomal proteins, including 336 differentially abundant candidates. Gliomasphere-derived exosomes were enriched in proteins associated with translation, RNA binding, actin organization, cytoskeletal regulation, and intracellular trafficking. Monolayer-derived exosomes were enriched in extracellular-matrix and stem-cell-niche components, including NID2, LAMA5, LAMB1, LAMB2, LAMC1, THBS1, TGFBI, IQGAP3, and APOE. Single-cell transcriptomic analysis showed that gliomasphere-derived exosomes prevented the radiation-induced expansion of neural progenitor-like cells, consistent with suppression of an induced stem-like state. Treatment of gliomaspheres with monolayer-derived exosomes left their overall cellular composition largely but enriched MYC-target, E2F-target, and oxidative-phosphorylation programs, suggesting that increased sphere formation may partly reflect enhanced proliferative capacity. Conclusions: GBM cells use exosomes to establish a bidirectional feedback circuit between stem-like and differentiated tumor-cell compartments. GIC-derived exosomes constrain radiation-induced conversion of non-stem glioma cells into GICs, whereas differentiated-cell-derived exosomes promote a niche that supports GIC maintenance and self-renewal, potentially through expansion of a mixed-vascular-like population containing neurovascular progenitors. Whether exosomal IQGAP3 contributes to the expansion of this GIC population remains to be determined. These findings identify exosome-mediated intercellular communication as a potential mechanism regulating GBM cellular homeostasis, treatment resistance, and recurrence.

neuroscience↗

miR-34/449 miRNAs regulate choroid plexus ciliogenesis to control cerebrospinal fluid production

A developmental increase in cerebrospinal fluid (CSF) production during development is essential for neuronal growth and ventricular expansion. A key regulator of CSF production is the specialized sensory multicilia of the choroid plexus (ChP), which mediate non-canonical Sonic hedgehog (Shh) signaling to suppress water channel and ion transporter expression, thereby limiting CSF production. ChP multicilia progressively shortens during development, attenuating Shh signaling and promoting CSF production. Here, we identify miR-34/449 miRNAs as essential regulators of ChP multiciliogenesis. Whereas mutations in canonical ciliogenesis genes elevate CSF production and contribute to hydrocephaly, deletion of miR-34/449 reduces CSF volume and causes microcephaly. Loss of miR-34/449 miRNAs causes excessive basal body amplification, defective basal body docking, and failure of developmental multiciliary shortening. Consequently, miR-34/449-deficient ChP cilia remain abnormally long and fail to attenuate Shh signaling, resulting in sustained repression of water channel and ion transporter expression and reduced CSF production. Mechanistically, miR-34/449 miRNAs directly target Gmnc, a master transcriptional regulator of multiciliogenesis, to restrain basal body amplification and promote basal body docking. Together, our findings identify miR-34/449 miRNAs as critical regulators of ChP multiciliogenesis and establish the developmental remodeling of ChP multicilia as a mechanism to couple Shh signaling dynamics to developmental control of CSF production.

developmental biology↗

RBP4-BACH1 Interaction Modulates Transcriptional Regulation of Insulin Signaling Pathway Genes

Retinol-binding protein 4 (RBP4) exhibits diurnal oscillatory pattern and is elevated under conditions of circadian disruption and in type 2 diabetes mellitus, yet the molecular link between RBP4 and impaired glucose metabolism remains elusive. Here, we overexpressed RBP4 in human hepatoma Huh7 cells and performed integrated RNA sequencing (RNA-seq), Co-immunoprecipitation (Co-IP) coupled with mass spectrometry (MS), and Cleavage Under Targets and Tagmentation (CUT&Tag). We identified BACH1 as a direct RBP4-interacting transcription factor that predominantly binds the TGACTCA motif in promoter regions of genes involved in carbon metabolism pathways. Integrative analysis of RNA-seq and CUT&Tag data uncovered 63 direct target genes co-regulated by RBP4 and BACH1, including known circadian and metabolic regulators SLC7A11, PFKFB3, CTCF, NR1D2 and WEE1 as well as novel candidates SF1 and PIN1. These target genes are significantly enriched in insulin receptor signaling and carbohydrate metabolic pathways. Mechanistically, the RBP4-BACH1 axis reprograms glucose metabolism, linking circadian rhythm disturbances to dysregulated glucose homeostasis. Collectively, our findings establish a functional role for RBP4 in connecting circadian disruption to diabetes and highlight RBP4 as a potential therapeutic target.

molecular biology↗

Kinesin-1 holoenzyme assembly coordinates cargo-adaptor recognition with heavy-chain autoinhibition

Kinesin-1 is a major microtubule-based molecular motor that transports diverse cellular cargoes, yet how assembly of its subunits is coupled to cargo recognition and motor regulation remains poorly understood. Mammalian kinesin-1 functions as a heterotetrameric holoenzyme composed of kinesin heavy chains (KIF5s) and kinesin light chains (KLCs), but the structural principles linking holoenzyme assembly to motor regulation remain unclear. Here, using KIF5C as a model system, we define the molecular mechanisms underlying kinesin-1 holoenzyme assembly and cargo-adaptor regulation. We identify a conserved coiled-coil interface between KIF5C and KLC1 that mediates their 2:2 assembly, with quantitative mutagenesis revealing key hydrophobic determinants of complex formation. We further demonstrate that the mitochondrial adaptor TRAK2 directly engages the KIF5C CC4 cargo-binding platform through a defined 2:2 interaction required for mitochondrial recruitment of KIF5C. Although KLC1 and TRAK2 bind distinct regions of KIF5C, KLC1 modulates TRAK2 association through steric and conformational effects, revealing how holoenzyme composition influences cargo-adaptor accessibility. Mechanistically, we identify a previously unrecognized intramolecular interaction between the KIF5C CC1 and CC4 domains that forms a stalk-mediated autoinhibitory latch. TRAK2 and KLC1 release this inhibitory interaction through distinct mechanisms. Together, our study establishes a molecular framework in which kinesin-1 holoenzyme assembly regulates cargo-adaptor recognition and autoinhibitory remodeling, providing mechanistic insight into how molecular motors coordinate cargo engagement with activation.

biochemistry↗

Leukemic Stem Cell Subtypes Drive Distinct Niche Remodeling in Acute Myeloid Leukemia

Leukemic stem cells (LSCs) sustain acute myeloid leukemia (AML) and are implicated in therapy resistance and relapse. Yet, it remains unknown how LSCs remodel the bone marrow niche. AML is known to alter stromal and vascular microenvironments, but these effects are difficult to separate from bulk leukemic burden and immune inflammation. Here, we use isogenic human AML xenografts with distinct LSC characteristics but comparable engraftment to define LSC-associated niche remodeling in vivo. Single-cell profiling revealed that LSC-high AML shifts the mesenchymal niche toward fibro-inflammatory states, expanding Fmod+ fibroblasts and Cd34+ perivascular fibroblast-like cells while suppressing osteolineage differentiation. The leukemic compartment remained heterogeneous, with a specific MEP-like LSC population expressing niche-remodeling ligands including TGFB1, IL1B, and ANGPT1. LSC-high AML activated a TGF{beta}-responsive, CREB3L1-controlled fibroblast trajectory, and perturbing TGF{beta} signaling or CREB3L1 activation reduced stromal support for AML cells. These findings identify a specific LSC subtype as a source of niche-remodeling cues that shape specialized leukemia-supportive niches.

molecular biology↗